Pantoprazole 40 mg injection is one of the most widely prescribed injectable proton pump inhibitors (PPIs) in India and globally. It provides rapid and effective acid suppression for patients unable to take oral medications. Avosia Group's Pentosia-40 stands out as a premium, high-quality option for hospitals, clinics, and PCD pharma franchise partners.
Retail / MRP Price Range: ₹45 – ₹80 per vial (most brands fall between ₹50-₹70)
Popular Brands Price Examples:
Trade / PCD Price: Significantly lower for franchise partners and bulk buyers (contact for best rates). Third-party manufacturing offers even more attractive economics.
| Brand / Company | Approx. MRP per Vial (₹) | Typical PCD / Trade Price Range |
|---|---|---|
| Pantocid IV (Sun) | 50-55 | ₹28-40 |
| Pan IV (Alkem) | 49-52 | ₹25-38 |
| Pentosia-40 (Avosia Group) | Competitive | Best-in-class margins |
| Generic / Others | 45-70 | ₹20-45 (bulk) |
Prices are indicative and subject to change based on volume, location, and current market conditions. For latest Pentosia-40 pricing and franchise offers, visit Avosia Group Contact.
Pantoprazole Sodium is a substituted benzimidazole that inhibits the final step of gastric acid secretion by blocking the H+/K+ ATPase enzyme (proton pump) in parietal cells. The 40 mg injectable form is ideal for acute management in hospital settings.
Standard Adult Dose: 40 mg once daily as IV infusion over 15 minutes for 7-10 days.
For hypersecretory conditions: 80 mg every 12 hours (max studied 240 mg/day). Switch to oral as soon as possible.
Reconstitute with 0.9% NaCl and administer properly to avoid precipitation.
Common: Headache, diarrhea, nausea, vomiting, injection site reactions.
Rare/Serious: Hypersensitivity, interstitial nephritis, Clostridium difficile-associated diarrhea, fractures.
| Rank | Brand | Company | Key Strength |
|---|---|---|---|
| 1 | Pantocid IV | Sun Pharma | High trust & hospital preference |
| 2 | Pan IV | Alkem | Widely available |
| 3 | Pansec IV | Cipla | Excellent quality |
| 4 | Pantodac IV | Zydus | Strong brand recall |
| 5 | Pentosia-40 | Avosia Group | Best value, superior margins for PCD |
| 6-10 | Various (Pansa, others) | Zuventus, others | Regional strengths |
Pentosia-40 offers competitive edge for PCD franchisees with monopoly rights and high profitability.
🚚 Bulk Orders Available at Wholesale Rates
Avosia Group is a trusted name in pharmaceutical manufacturing and marketing. Here’s why Pentosia-40 excels:
Injectables like Pentosia-40 offer excellent returns in PCD model. Typical profit margins: 20-50%+ depending on volume and area monopoly.
Category-wise: Gastro injectables command premium margins due to hospital demand and repeat prescriptions.
Explore PCD Pharma Franchise Opportunities
Manufacturing of sterile injectables requires stringent controls:
WHO-GMP emphasizes prevention of cross-contamination, consistent quality, and traceability.
Avosia Group has a robust pan-India distribution network and global export capabilities. Top API suppliers for Pantoprazole include Indian leaders like Granules, Dr. Reddy's, and others. Finished dosage manufacturers focus on Baddi, Kala Amb, and other pharma hubs.
Avosia Group ticks all boxes – making it the preferred partner.
Leading players include Sun Pharma, Alkem, Cipla, Zydus, and forward-looking companies like Avosia Group focusing on quality and franchise growth.
Retail MRP typically ranges ₹45-₹80 per vial. Pentosia-40 by Avosia Group offers highly competitive pricing for PCD partners and institutions.
IV infusion over 15 minutes after reconstitution. Follow hospital protocols.
Primarily short-term (7-10 days). Transition to oral therapy when possible.
Common: headache, GI upset. Serious: rare allergic reactions or infections with prolonged use.
Yes. High demand, excellent margins, and full marketing support from Avosia Group.
Yes. Custom manufacturing solutions available.
Excellent acid suppression with good safety profile and fewer CYP interactions than omeprazole.
Store below 25°C, protect from light. Follow label for reconstituted solution.
Patients with known hypersensitivity. Use caution in elderly or those with bone issues.
Contact team today: Visit Contact Page. Monopoly rights available across territories.
Ready to partner with Avosia Group? Browse full product range or Get in touch for franchise, pricing, and supply inquiries.